#KidneyWk on X 12 hours ago

In an interim analysis of the ORIGIN 3 clinical trial, the novel IgA nephropathy drug atacicept nearly halved proteinuria among adults with IgA nep...

View Post

#KidneyWk on X 14 hours ago

WATCH Matthew Weir, MD, discussing results from the phase 2 Explore-CKD trial of lorundrostat presented at #KidneyWk. #nephrology #nephtwitter #ki...

View Post

#KidneyWk on X 1 day ago

RT @kidney_boy: Who and how to give an SGLT2i to a type 1 DM patient #KidneyWk https://t.co/VfsBBnuIWw

View Post

#KidneyWk on X 1 day ago

One week left! Don’t miss your chance to claim continuing education credits and MOC points. If you attended #KidneyWk, be sure to: ✅ Complete eval...

View Post

#KidneyWk on X 1 day ago

RT @NEJM: Original Article: Fish-Oil Supplementation and Cardiovascular Events in Patients Receiving Hemodialysis (PISCES trial) https://t.…

View Post

#KidneyWk on X 2 days ago

RT @Mafer_ZavalaM: A really amazing experience for our @NefroINCMNSZ #Glomerular team 🇲🇽 in the #KidneyWk at @ASNKidney! Really proud for…

View Post

#KidneyWk on X 2 days ago

Therapies for IgA nephropathy and lupus took center stage in the High-Impact Trials sessions at ASN Kidney Week 2025. Read about a trio of therapie...

View Post

#KidneyWk on X 3 days ago

At #KidneyWk, @ASNKidney experts discussed the organization’s new AI framework, focusing on: ⭐ How AI use can benefit patients ⭐ How physicians sh...

View Post

#KidneyWk on X Sunday, December 7 @ 12:44 PM

RT @edgarvlermamd: BOMBACK: Complications of Nephrotic Syndrome - AKI #KidneyWk #Nephpearls https://t.co/LSMoEwumUC

View Post

#KidneyWk on X Sunday, December 7 @ 6:58 AM

RT @AGallegosMD: My favorite session of the day 😊 @LRCASTEL @DrJayMohan @HeartOTXHeartMD @DmitryAbramovMD @LLNeph @ucsdnephrology @UCSDCar…

View Post